Aclaris Therapeutics Inc buy BiotechBee
Start price
03.01.23
/
60%
€14.22
Target price
31.12.25
€20.00
Performance (%)
-43.02%
End price
05.05.23
€8.10
Summary
This prediction ended on 05.05.23 with a price of €8.10. Massive losses of -43.02% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Aclaris Therapeutics Inc | 1.758% | 1.758% | -82.726% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to BiotechBee what are the pros and cons of Aclaris Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aclaris Therapeutics Inc diskutieren
Buy mit Kursziel 20,0
In the thread Trading Aclaris Therapeutics Inc
Buy beendet
Stopped prediction by BiotechBee for Aclaris Therapeutics Inc
Aclaris Therapeutics Inc
Start price
Target price
Perf. (%)
€1.07
12.11.23
12.11.23
€6.00
31.07.25
31.07.25
-
13.11.23
13.11.23
Could be very worthwhile Investment >20% year